spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  maraviroc 

 HSMN NewsFeed - 8 Oct 2009
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 8 Apr 2008
New York Medicaid Program Establishes Coverage for Trofile(TM)
Diagnostics Biopharmaceuticals HIV/AIDS Reimbursement
 HSMN NewsFeed - 6 Feb 2008
Pfizer Presents New Data from HIV/AIDS Portfolio at Conference on Retroviruses and Opportunistic Infections
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 7 Nov 2007
Monogram Obtains Coverage for Trofile(TM) Assay from California ADAP Program
Diagnostics Reimbursement HIV/AIDS
 HSMN NewsFeed - 24 Sep 2007
Pfizer's Celsentri(R) Approved in the European Union, Providing a Novel Treatment Option for Treatment-Experienced HIV Patients
Biopharmaceuticals HIV/AIDS Regulatory
 HSMN NewsFeed - 18 Sep 2007
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc)
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2007
Monogram Announces Commercial Introduction of Trofile(TM) Assay
Diagnostics HIV/AIDS
 HSMN NewsFeed - 6 Aug 2007
Pfizer's SelzentryTM (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 25 Jul 2007
Maraviroc Reduces HIV Viral Load in Treatment-Naive Patients, 48 Week Data Show
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 20 Jul 2007
European Committee Issues Positive Opinion of Pfizer's Celsentri(R) (Maraviroc) for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 20 Jun 2007
Pfizer Receives Approvable Letter From FDA For Maraviroc
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 20 May 2007
Pfizer Says Research and Development Head John LaMattina Will Retire This Year
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2007
FDA Advisory Committee Recommends Accelerated Approval of Pfizer's Maraviroc for Treatment-Experienced Patients Infected with CCR5-tropic HIV-1
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 1 Mar 2007
Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 13 Feb 2007
Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
Biopharmaceuticals Regulatory HIV/AIDS
 HSMN NewsFeed - 1 Dec 2006
Pfizer Announces Plans to Establish Expanded Access Program for Maraviroc, Investigational HIV CCR5 Antagonist
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 8 May 2006
Pfizer to Invest $25 Million in Monogram
Diagnostics Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 8 May 2006
Pfizer and Monogram to Make HIV Co-Receptor Tropism Assay Available Globally
Diagnostics Biopharmaceuticals HIV/AIDS
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.